| 1 | Scholar Rock Holding Corp | 1 035 496 | 50,9 M $ | |
| 2 | Abivax SA | 313 791 | 34,9 M $ | |
| 3 | Syndax Pharmaceuticals Inc | 1 215 743 | 28,4 M $ | |
| 4 | Revolution Medicines Inc | 281 632 | 27,4 M $ | |
| 5 | Immunovant Inc | 746 494 | 18,5 M $ | |
| 6 | Praxis Precision Medicines Inc | 56 267 | 18,1 M $ | |
| 7 | MBX Biosciences Inc | 499 469 | 14,9 M $ | |
| 8 | Mineralys Therapeutics Inc | 533 378 | 14,4 M $ | |
| 9 | Enliven Therapeutics Inc | 363 438 | 14,2 M $ | |
| 10 | CG oncology Inc | 205 622 | 13,9 M $ | |
| 11 | Surrozen Inc | 525 639 | 13,5 M $ | |
| 12 | EyePoint Inc | 810 764 | 10,5 M $ | |
| 13 | Arcutis Biotherapeutics Inc | 413 792 | 9,7 M $ | |
| 14 | Structure Therapeutics Inc | 200 267 | 9,7 M $ | |
| 15 | Amylyx Pharmaceuticals Inc | 669 685 | 9,3 M $ | |
| 16 | Dyne Therapeutics Inc | 506 075 | 9,2 M $ | |
| 17 | Edgewise Therapeutics Inc | 290 864 | 9,2 M $ | |
| 18 | Cytokinetics Inc | 129 577 | 8,5 M $ | |
| 19 | Spyre Therapeutics Inc | 167 606 | 8,5 M $ | |
| 20 | Denali Therapeutics Inc | 426 561 | 8,2 M $ | |
| 21 | Celldex Therapeutics Inc | 254 267 | 8,1 M $ | |
| 22 | Protagonist Therapeutics Inc | 72 577 | 7,6 M $ | |
| 23 | Tyra Biosciences Inc | 193 177 | 7,4 M $ | |
| 24 | Dianthus Therapeutics Inc | 85 502 | 7,2 M $ | |
| 25 | Celcuity Inc | 60 062 | 6,9 M $ | |
| 26 | BioAge Labs Inc | 338 654 | 5,9 M $ | |
| 27 | ACADIA Pharmaceuticals Inc | 242 566 | 5,4 M $ | |
| 28 | Assembly Biosciences Inc | 185 435 | 5,1 M $ | |
| 29 | Alumis Inc | 229 566 | 5,1 M $ | |
| 30 | Nurix Therapeutics Inc | 315 226 | 4,9 M $ | |
| 31 | Evommune Inc | 193 777 | 4,4 M $ | |
| 32 | Tango Therapeutics Inc | 200 919 | 4,2 M $ | |
| 33 | SENSEI BIOTHERAPEUTICS INC | 132 873 | 4,2 M $ | |
| 34 | Relmada Therapeutics Inc | 597 409 | 4,2 M $ | |
| 35 | Erasca Inc | 239 861 | 3,9 M $ | |
| 36 | Johnson & Johnson | 15 415 | 3,8 M $ | |
| 37 | X4 PHARMACEUTICALS INC | 850 742 | 3,5 M $ | |
| 38 | Vaxcyte Inc | 59 061 | 3,4 M $ | |
| 39 | Aadi Bioscience Inc | 939 369 | 3,2 M $ | |
| 40 | Tenax Therapeutics Inc | 188 700 | 3 M $ | |
| 41 | Invivyd Inc | 1 874 546 | 2,4 M $ | |
| 42 | JADE BIOSCIENCES INC | 154 034 | 2,2 M $ | |
| 43 | Twist Bioscience Corp | 43 110 | 2 M $ | |
| 44 | MapLight Therapeutics Inc | 100 000 | 2 M $ | |
| 45 | AVALO THERAPEUTICS INC | 134 742 | 2 M $ | |
| 46 | Ionis Pharmaceuticals Inc | 26 385 | 2 M $ | |
| 47 | Immunocore Holdings PLC | 63 543 | 1,9 M $ | |
| 48 | Forte Biosciences Inc | 58 020 | 1,5 M $ | |
| 49 | Sionna Therapeutics Inc | 36 540 | 1,5 M $ | |
| 50 | SAB Biotherapeutics Inc | 375 000 | 1,4 M $ | |
| 51 | Solid Biosciences Inc | 195 403 | 1,4 M $ | |
| 52 | Lipocine Inc | 160 420 | 1,3 M $ | |
| 53 | LB Pharmaceuticals Inc | 50 000 | 1,2 M $ | |
| 54 | C4 Therapeutics Inc | 453 236 | 1,2 M $ | |
| 55 | Edwards Lifesciences Corp | 14 588 | 1,2 M $ | |
| 56 | Capricor Therapeutics Inc | 37 592 | 1,1 M $ | |
| 57 | BIODESIX INC | 70 004 | 1 M $ | |
| 58 | Sutro Biopharma Inc | 23 295 | 580,3 k $ | |
| 59 | SPRUCE BIOSCIENCES INC | 6 360 | 415,6 k $ | |
| 60 | VISTAGEN THERAPEUTICS INC | 616 749 | 58,2 k $ | |